Infectio Diagnostic Inc. (Sainte-Foy, Quebec, Canada) received FDA approval for IDI-MRSA, its new ultra-rapid test for detecting methicillin-resistant Staphylococcus aureus (MRSA). IDI-MRSA is the first test approved for use directly on clinical samples.

Traditional methods of testing for MRSA require 2 to 5 days, while the IDI-MRSA test provides test results within 1 hour. The rapidity of the new test will significantly reduce the costs to healthcare institutions fighting and preventing the spread of these infections.

For more information, visit http://www.infectio.com.